INTERMEDICAL CARE AND LAB HOSPITAL PUBLIC COMPANY LIMITED INTERNATIONAL NET WORK SYSTEM PUBLIC COMPANY LIMITED INTERNATIONAL RESEARCH CORPORATION PUBLIC COMPANY LIMITED INTERNET THAILAND PUBLIC COMPANY LIMITED
INTERMEDICAL CARE AND LAB HOSPITAL PUBLIC COMPANY LIMITED INTERNATIONAL NET WORK SYSTEM PUBLIC COMPANY LIMITED INTERNATIONAL RESEARCH CORPORATION PUBLIC COMPANY LIMITED INTERNET THAILAND PUBLIC COMPANY LIMITED
INTERMEDICAL CARE AND LAB HOSPITAL PUBLIC COMPANY LIMITED INTERNATIONAL NET WORK SYSTEM PUBLIC COMPANY LIMITED INTERNATIONAL RESEARCH CORPORATION PUBLIC COMPANY LIMITED INTERNET THAILAND PUBLIC COMPANY LIMITED
INTERMEDICAL CARE AND LAB HOSPITAL PUBLIC COMPANY LIMITED INTERNATIONAL NET WORK SYSTEM PUBLIC COMPANY LIMITED INTERNATIONAL RESEARCH CORPORATION PUBLIC COMPANY LIMITED INTERNET THAILAND PUBLIC COMPANY LIMITED
INTERMEDICAL CARE AND LAB HOSPITAL PUBLIC COMPANY LIMITED INTERNATIONAL NET WORK SYSTEM PUBLIC COMPANY LIMITED INTERNATIONAL RESEARCH CORPORATION PUBLIC COMPANY LIMITED INTERNET THAILAND PUBLIC COMPANY LIMITED
% % Administrative expenses to sales 11.1% 10.7% Finance costs 16.4 16.2 +2% Share of profit (loss) from investment in subsidiaries and joint ventures (1) (1.5) +35% Tax (income) 0 (16) +101% Net profit (loss) major
-Current Liabilities 134.27 393.84 -259.57 -65.91 Total Liabitities 434.67 799.66 -364.99 -45.64 Total Shareholders ' Equity -26.39 251.79 -278.18 -110.48 Basic Loss Per Share (Baht) (0.35) (0.36) Gross
95.0 22.3 Total Expenses 11,482.6 69.0 9,621.5 68.1 (1,861.2) (16.2) Profit before share of loss from investments in joint ventures, finance cost and income tax expenses 5,155.2 31.0 4,500.7 31.9 (654.5
INTERMEDICAL CARE AND LAB HOSPITAL PUBLIC COMPANY LIMITED INTERNATIONAL NET WORK SYSTEM PUBLIC COMPANY LIMITED INTERNATIONAL RESEARCH CORPORATION PUBLIC COMPANY LIMITED INTERNET THAILAND PUBLIC COMPANY LIMITED
having shareholder being person as prescribed in (1) to (13) combining hold shares exceed 75% of share which entitle to vote; (15) foreign investors having qualifications as the investor prescribed in (1